Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Features of Myasthenia Gravis With Antibodies to MuSK Based on Age at Onset: A Multicenter Retrospective Study in China. | Front Neurol | 2022 | 35463138 | PubTator, text mining | PubMed |
| SARS-CoV-2 triggering autoimmune diseases. | Cytokine | 2022 | 35461172 | PubTator, text mining | PubMed |
| Exploring the Gut Microbiome in Myasthenia Gravis. | Nutrients | 2022 | 35458209 | PubTator, text mining | PubMed |
| Preferential X Chromosome Inactivation as a Mechanism to Explain Female Preponderance in Myasthenia Gravis. | Genes (Basel) | 2022 | 35456502 | PubTator, text mining | PubMed |
| Quality of Life in Myasthenia Gravis and Correlation of MG-QOL15 with Other Functional Scales. | J Clin Med | 2022 | 35456281 | PubTator, text mining | PubMed |
| Neurophysiological challenges in myasthenia gravis associated with MuSK antibodies: a case report. | Neurol Sci | 2022 | 35441276 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration. | Front Cell Dev Biol | 2022 | 35433700 | PubTator, text mining | PubMed |
| Studying the relationship between clinical features and mental health among late-onset myasthenia gravis patients. | World J Psychiatry | 2022 | 35433329 | PubTator, text mining | PubMed |
| The LINC00452/miR-204/CHST4 Axis Regulating Thymic Tregs Might Be Involved in the Progression of Thymoma-Associated Myasthenia Gravis. | Front Neurol | 2022 | 35432149 | PubTator, text mining | PubMed |
| EGFR/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli. | Cell Death Dis | 2022 | 35428350 | PubTator, text mining | PubMed |
| Analysis of nAChR Autoantibodies Against Extracellular Epitopes in MG Patients. | Front Neurol | 2022 | 35418927 | PubTator, text mining | PubMed |
| Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients. | J Neuroinflammation | 2022 | 35413850 | PubTator, text mining | PubMed |
| Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study. | Neurol Ther | 2022 | 35412216 | PubTator, text mining | PubMed |
| Myasthenia Gravis: An Acquired Interferonopathy? | Cells | 2022 | 35406782 | PubTator, text mining | PubMed |
| CRABP1 in Non-Canonical Activities of Retinoic Acid in Health and Diseases. | Nutrients | 2022 | 35406141 | PubTator, text mining | PubMed |
| Integrated Analysis of Competitive Endogenous RNA Networks in Acute Ischemic Stroke. | Front Genet | 2022 | 35401659 | PubTator, text mining | PubMed |
| IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies. | Front Immunol | 2022 | 35401530 | PubTator, text mining | PubMed |
| An Amish founder population reveals rare-population genetic determinants of the human lipidome. | Commun Biol | 2022 | 35393526 | PubTator, text mining | PubMed |
| Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience. | Eur J Neurol | 2022 | 35390184 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=45